Gary Ingenito
Chief Tech/Sci/R&D Officer presso CATALYST PHARMACEUTICALS, INC.
Patrimonio netto: 819 173 $ in data 31/03/2024
Profilo
Gary Ingenito is currently the Chief Medical & Regulatory Officer at Catalyst Pharmaceuticals, Inc. He previously held positions as Senior Vice President at inVentiv Health Clinical, Inc. from 2003 to 2005, Senior Vice President-Scientific Affairs at Ontrak, Inc., Chief Clinical & Regulatory Affairs Officer at Angiotech Pharmaceuticals, Inc. from 2005 to 2008, Head-Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc., and Head-Medical Affairs at Sandoz Pharmaceuticals Corp.
Dr. Ingenito has a doctorate degree from Thomas Jefferson University and Sidney Kimmel Medical College, an undergraduate degree from The Johns Hopkins University, and a graduate degree from the University of Miami.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/02/2024 | 51 391 ( 0.04% ) | 819 173 $ | 31/03/2024 |
Posizioni attive di Gary Ingenito
Società | Posizione | Inizio |
---|---|---|
CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
Precedenti posizioni note di Gary Ingenito
Società | Posizione | Fine |
---|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 29/02/2008 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/01/2005 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | General Counsel | - |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - |
ONTRAK, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Gary Ingenito
Thomas Jefferson University | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
University of Miami | Graduate Degree |
Sidney Kimmel Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ONTRAK, INC. | Health Services |
CATALYST PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 4 |
---|---|
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Sandoz Pharmaceuticals Corp. |
- Borsa valori
- Insiders
- Gary Ingenito